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ABSTRACT

Human papillomavirus (HPV) is one of the most common sexually transmitted diseases
and can cause several types of cancer, including cervical and anal cancer. The lesbian, gay,
bisexual, and transgender (LGBT) population is an often overlooked subgroup at risk for HPV.
The purpose of this research was to describe LGBT college students‟ knowledge, attitudes, and
behaviors pertaining to HPV and the HPV vaccine. An online survey consisting of 54 items was
created and sent to members of an organization consisting primarily of LGBT students at the
University of South Florida. A total of 155 students completed the survey. Several major
premises were identified: most students had heard of HPV and were fairly knowledgeable about
the general concept, but were much less knowledge when it came to specific details. Most
students agreed that HPV and HPV-related disease were serious, but did not perceive themselves
to be at risk for contracting HPV. Approximately one-third of participants received the HPV
vaccine, and while over half of participants reported condom use, use of other safer sex barrier
methods was lacking. By conducting this exploratory survey, we were able to identify and
understand factors associated with preventive sexual health measures (i.e., HPV vaccination),
which may serve as an important step toward developing and planning interventions to promote
these measures in the future.

Key Words: human papillomavirus, HPV vaccine, LGBT, college students

iii

ACKNOWLEDGEMENTS

I just wanted to say thank you to Kristen Shalosky, for your inspiration and endless
advice. I also wanted to thank the P.R.I.D.E. Alliance executive board for making this all
possible. Also, thank you my thesis committee Drs. Vadaparampil, Malo, and Quinn for their
direction. Thank you to Dr. Julie Christie and Cheryl Miree for all of your support and guidance
along the way. A special thanks goes to my family for all your care and support with all of my
endeavors.

iv

TABLE OF CONTENTS
Page
ABSTRACT .................................................................................................................................. ii
ACKNOWLEDGEMENTS ........................................................................................................ iii
LIST OF TABLES ....................................................................................................................... vi
SECTION
1

INTRODUCTION........................................................................................................1
1.1 Overview of HPV ............................................................................................1

2

3

1.2

HPV Vaccine ..................................................................................................2

1.3

HPV and the LGBT Population ......................................................................3

1.4

Purpose of Study .............................................................................................4

METHODS ...................................................................................................................5
2.1

Participant Recruitment ..................................................................................5

2.2

Survey Development .......................................................................................6

2.3

Data Collection, Management, and Analysis ..................................................9

RESULTS ...................................................................................................................10
3.1

Demographics ...............................................................................................10

3.2

HPV Knowledge ...........................................................................................12

3.3

Sexual Health Behaviors ...............................................................................14

3.4

HPV Vaccine ................................................................................................19

3.5

Attitudes, Beliefs, and Perceptions ...............................................................20

3.6 Health Care Experiences ................................................................................22

v
4

5

DISCUSSION .............................................................................................................25
4.1

Overview .......................................................................................................25

4.2

Knowledge of Participants ............................................................................25

4.3

Attitudes of Participants ................................................................................28

4.4

Behaviors of Participants ..............................................................................30

CONCLUSIONS ........................................................................................................32
5.1 Findings and Implications ..............................................................................32
5.2 Limitations .....................................................................................................33

REFERENCES .............................................................................................................................34
APPENDICES
A Consent Cover Sheet ..................................................................................................38
B Quantitative Survey ...................................................................................................39
C Gift Card Raffle Information Sheet .........................................................................50
D Letter of Approval from P.R.I.D.E. Alliance President .........................................51
E Respondent Debriefing Questionnaire .....................................................................52
F IRB Approval Form ...................................................................................................54

vi

LIST OF TABLES
Page
Table 1: Demographics ..................................................................................................................10
Table 2: HPV Knowledge ..............................................................................................................13
Table 3: HPV Knowledge Scores ..................................................................................................14
Table 4: Sexual Health Behaviors..................................................................................................15
Table 5: HPV Vaccine ...................................................................................................................19
Table 6: Attitudes, Beliefs, and Perceptions ..................................................................................21
Table 7: Health Care Experiences..................................................................................................23

1
SECTION 1: INTRODUCTION

1.1 Overview of HPV
Genital human papillomavirus (HPV) is among the most common sexually transmitted
infections in the world (Dunne et al., 2007). The World Health Organization estimates that 630
million people are infected with HPV worldwide (Forcier & Musacchio, 2010). Approximately
20 million Americans are currently infected with HPV and an additional 6 million people
become infected each year (CDC, 2009). The virus is so common that at least 50% of sexually
active men and women will be infected with HPV at some point in their lives (CDC, 2009).
While the majority of HPV infection clears without medical intervention (CDC, 2009), persistent
HPV infection causes nearly all cases of cervical cancers (99.7%) and has been strongly
associated with anal cancer in men and women (Daling et al., 1987; Peltecu, Bari, Lancu, &
Popa, 2009). Approximately 12,000 women get cervical cancer in the U.S. each year (CDC,
2009). Anal cancer affects approximately 3,400 men and women in the U.S. annually and has
increased over 35% among women in the past 15 years. Approximately 50% of cancers of the
vulva, vagina, and penis may also be attributable to HPV infection, as well as 20% of
oropharyngeal cancers and 10% of cancers of the larynx, respiratory and digestive tracts
(Giuliano & Viscidi, 2007). Approximately 6% of the estimated 9 million cases of cancer
worldwide per year may be attributable to HPV infection (Frazer, 1999). The majority of
infections are transient and subclinical, with approximately 90% of infections being low grade
(CDC, 2009), non-cancer causing and clearing within two years. Although only 1% of infections
progress to invasive cancer, the public health impact is great with several million individuals
worldwide developing HPV-associated cancer (Forcier & Musacchio, 2010).
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Since HPV usually clears without medical intervention within two years, causes no signs
and symptoms, and is common, routine DNA based HPV testing is currently not recommended
(CDC, 2009). Women are encouraged to get routine cervical cancer screening tests, such as the
Papanicalou (Pap) test, which can find abnormal cells on the cervix so that they can be removed
before cancer develops (CDC, 2009). An HPV DNA test may be used in conjunction with a Pap
test in certain cases, such as when a Pap test result is mildly abnormal (CDC, 2009; Foundation,
2011). There is no approved screening test to find HPV in men or early signs of penile or anal
cancer, but some experts recommend yearly anal Pap tests to screen for anal cancer in gay and
bisexual men and in HIV-positive persons because of the higher incidence of anal cancer in these
populations (CDC, 2010b).

1.2 HPV Vaccine
The HPV vaccine aims to prevent the HPV types that cause cervical cancer. There are
currently two HPV vaccines: Gardasil and Cervarix. Both confer immunity against HPV types
16 and 18, which account for about 70% of cervical cancers. Gardasil additionally protects
against types 6 and 11, which cause 90% of anogenital warts (Saslow et al., 2007). The vaccines
have been approved and recommended for females, and more recently, males ages 9 to 26 years
of age for the prevention of cervical, vulvar, and vaginal cancer (FDA, 2010; McRee, Reiter,
Chantala, & Brewer, 2010). In October 2010, Garadasil was approved for prevention of anal
cancer in both males and females (FDA, 2010).
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1.3 HPV and the Lesbian, Gay, Bisexual, and Transgender (LGBT) Population
Although several studies have examined knowledge and attitudes related to HPV
infection across college campuses, the primary focus has been on differences by ethnicity and
gender (Baer, Allen, & Braun, 2000; D'Urso, Thompson-Robinson, & Chandler, 2007; Daley et
al., 2010; Gerend & Magloire, 2008; Li Ping & Sam, 2010; Vogtmann, Harlow, Valdez, Valdez,
& Ponce, 2010). An overlooked subgroup that may be at risk for HPV infection is the lesbian,
gay, bisexual, and transgender (LGBT) college student population. Primary care for women
tends to be organized around reproductive health needs and since pregnancy is not as big of a
concern for lesbians, they might skip out on routine care (Solarz, 1999). Also, members of the
LGBT community may feel uncomfortable if their primary care provider does not agree with
their sexual orientation or gender identity, which could cause them to miss out on routine care as
well (Petroll & Mosack, 2010; Power, McNair, & Carr, 2009). In addition, there is a lack of
sexual health educational materials directed at the LGBT population that could lead to unsafe
sexual practices and increased exposure to infection.
HPV-related disease is a growing concern for gay and bisexual men (Reiter, Brewer,
McRee, Gilbert, & Smith, 2010). In the U.S., approximately 63% of oropharyngeal cancers,
93% of anal cancers, and 36% of penile cancers are attributable to HPV infection (mainly types
16 and 18) (Reiter et al., 2010). An estimated 60% of gay and bisexual men have anal HPV
infection and numbers increase to over 90% for HIV-infected individuals (Reiter et al., 2010).
The incidence of anal cancer in sexually active gay men is higher than cervical cancer in women
(Pitts, Fox, Willis, & Anderson, 2007). Men who have sex with men (MSM) are 17 times more
likely to develop anal cancer than heterosexual men (CDC, 2010a). Additionally, bisexual
women were 60% more likely to report having a sexually transmitted disease during the past
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year than their heterosexual counterparts (Lindley, Barnett, Brandt, Hardin, & Burcin, 2008).
There is a common misconception that sexually transmitted infections (STIs) cannot be
transmitted between women, despite recent evidence that lesbian at bisexual women are at risk
for many STIs, including HPV infection (Power et al., 2009). Data from the National Women‟s
Health Information Center also suggest lesbians are less likely to visit a doctor or nurse for
routine screenings, including Pap testing. In addition, some women and their doctors may
assume that lesbians do not need a regular Pap test (Center, 2005). Women who have sex with
women (WSW) may not see themselves as having HPV or other STIs because they do not
engage in sexual intercourse with men (Eaton et al., 2008). However, the majority of WSW have
been sexual with men at some point in their lives and may still carry HPV (Eaton et al., 2008).
WSW can contract HPV from a female partner as well (Eaton et al., 2008). The lack of health
promotion materials specific to lesbian and bisexual women may further reinforce these
misconceptions (Eaton et al., 2008).
Given the potential for HPV vaccine to confer protection against multiple HPVassociated cancers (Saslow et al., 2007), understanding knowledge and awareness related to HPV
vaccine among understudied populations (e.g. LGBT population) and particularly among highrisk subgroups (e.g., homosexual men) may be an important step toward prevention.

1.4 Purpose of Study
More information is needed regarding the knowledge, attitudes, and behaviors related to
HPV infection and HPV vaccination in the LGBT student population. The purpose of the current
study, therefore, is to describe the degree of knowledge; current state of attitudes, beliefs, and
perceptions; and sexual health behaviors related to HPV and HPV prevention in the LGBT
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community. Gaining information regarding HPV-related knowledge, attitudes, and behaviors
will serve as an important step toward developing and planning interventions to promote uptake
of vaccination in this community.

SECTION 2: METHODS

2.1 Participant Recruitment
People Respecting Individual Diversity and Equality (P.R.I.D.E.) Alliance is an LGBT
advocacy student organization based at the University of South Florida (USF) with
approximately 600 students registered on its list serve. P.R.I.D.E. members include many
lesbian, gay, bisexual, and a few transgender students. P.R.I.D.E. Alliance also includes Allies,
which are heterosexuals that support LGBT equality. P.R.I.D.E. Alliance holds weekly meetings
with an attendance of 30-50 students. We received permission from the president of P.R.I.D.E.
Alliance to survey members at P.R.I.D.E. Alliance meetings. In order to reach more P.R.I.D.E.
Alliance members, we also contacted members through the P.R.I.D.E. Alliance email list serve.
The study was approved by the Moffitt Cancer Center‟s Scientific Review Committee and the
USF Institutional Review Board (IRB). Given the minimal risk nature of this study and the
ability to complete the survey anonymously, the IRB granted a waiver of informed consent.
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2.2 Survey Development
The study team developed a 54-question survey to measure college students‟ HPV and
HPV vaccine related knowledge, attitudes, and behaviors. The survey includes six sections:
HPV Knowledge; Sexual Health Behaviors; HPV Vaccine; Attitudes, Beliefs and Perceptions;
Health Care Experiences; and Demographic Characteristics. The survey was 12 pages in length
and took approximately 20 minutes to complete.
The majority of survey questions were adapted from questionnaires developed by
Boehner and colleagues (2003), Yacobi and colleagues (1999), Power and colleagues (2009),
Reiter and colleagues (2010), Bynum and colleagues (2010), and Daley and colleagues (2010).
In addition, several knowledge questions were constructed by our investigative team based on
information from the Centers for Disease Control and Prevention‟s HPV Fact Sheet (CDC,
2009).

Survey Instrument (See Appendix B)
1. Knowledge (Section 1, #1,2a-y)
There are 25 items in this section to determine participants‟ HPV knowledge (e.g.,
“You can always tell when someone has HPV”). Participants were asked to respond
“yes, no, or don‟t know/not sure” to each statement. Responses were categorized based
on the total number of items answered correctly. The last three items in the section did
not count towards the participants‟ composite knowledge score, but were designed to aid
in a better understanding of LGBT-specific HPV knowledge and perceived risk (e.g.,
“Lesbians are at a much lower risk for getting HPV than women who have sex with
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men”). The first question asked if the participant had ever heard of HPV. Participants
who were not aware of HPV were directed to skip the remaining items in this section.
2. Sexual Health Behaviors (Section 2, #3-22)
There are 19 items in this section pertaining to sexual health behaviors. These items
pertain to sexual activity (e.g., “Are you sexually experienced [had vaginal, anal, or oral
sex]”), sexual health practices (e.g., “How long has it been since you had your last Pap
smear?”), partner interactions (e.g., “If you are sexually active, do you ask your sexual
partner[s] if they have been tested for sexually transmitted infections [STIs] or sexually
transmitted diseases [STDs]?”), and HPV previous exposure (e.g., “Have you ever been
diagnosed with HPV or genital warts?”). Participants were asked to respond “yes/no,” to
indicate the frequency of the behavior in question, or to provide a categorical answer
based on the scale provided.
3. HPV Vaccine (Section 3, #23-27)
There are five items in this section related to the HPV vaccine. These questions
include HPV vaccine previous exposure and practices regarding the HPV vaccine (e.g.,
“Before this survey, had you ever heard of the HPV vaccine? This vaccine is also referred
to as the HPV shot, GARDASIL, or CERVARIX.”). Participants were asked to respond
“yes/no” or to provide a categorical answer based on the scale provided.
4. Attitudes, Beliefs, and Perceptions (Section 4, #28a-p)
There are 16 items in this section relating to attitudes, beliefs, and perceptions
about HPV and the HPV Vaccine (e.g., “It is extremely likely that I will get HPV in my
lifetime”). Participants were asked to respond to each statement on a 5-point Likert-type
scale (1=strongly disagree, 5=strongly agree).
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5. Health Care Experiences (Section 5, #29-45)
There are 16 items in this section pertaining to health care experiences. These
questions include: the doctor‟s sexual orientation and gender identity (e.g., “What is your
doctor‟s gender?”), the participant‟s relationship with the doctor (e.g., “How comfortable
does your doctor seem to be with your sexual orientation?”), and whether the
participant‟s doctor has discussed HPV, other STIs, or the HPV vaccine with him/her
(e.g., “Has your doctor ever talked to you about the HPV vaccine?”). Participants were
asked to respond “yes/no,” to indicate his/her perceived degree of comfort or importance
on a 4-point Likert-type scale (e.g., 1= not at all comfortable, 4=very comfortable), or to
provide a categorical answer based on the scale provided.
6. Demographic Characteristics (Section 6, #46-54)
This section consisted of eight demographic items. These questions include
gender identity (female; male; MTF transgender; FTM transgender; other), sexual
orientation (heterosexual; homosexual; bisexual; questioning; other), age, ethnicity
(American Indian or Alaska Native; Asian; Black or African American; Hispanic or
Latino; Native Hawaiian or other Pacific Islander; White; more than once race; other),
college major (Science; Liberal Arts; Business; History; Social Sciences; Math;
Education; other), health-related career (yes; no; don‟t know/undecided), year in college
(freshman; sophomore; junior; senior; graduate student), relationship status (single or
never married; living with a domestic partner; married; divorced or separated; widowed;
other), and health insurance coverage (yes; no; don‟t know/not sure).
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Prior to initiating data collection with P.R.I.D.E Alliance members, the survey was pilot
tested with five P.R.I.D.E. Alliance executive board members. They were asked to comment on
survey items with regard to comprehension, clarity, and acceptability using a Respondent
Debriefing Questionnaire (see Appendix E). After completing the survey, participants also were
encouraged to make general suggestions to improve the survey. Revisions were made based on
members‟ feedback before the final survey was distributed to main study participants.

2.3 Data Collection, Management, and Analysis
Students on P.R.I.D.E. Alliance‟s list serve were emailed a brief description of the study
with a link to the web-based survey (using SurveyMonkey®). The survey was available for one
week. During the data collection period, students attending P.R.I.D.E. Alliance meetings were
also were given the option of completing the web-based survey via computers available at the
meeting location.
Students who chose to participate in the study were given the opportunity to enter a
drawing for one of four $25 gift certificates. Personal information for the drawing was collected
separate from the survey to maintain participant confidentiality. The drawing was held at the end
of the data collection period, after which all personal contact information provided by
participants was destroyed.
Data from the web surveys was exported into Microsoft Excel spreadsheet. Descriptive
statistics for the data were then analyzed using PASW v. 18.0. For all analyses, statistical
significance was defined at the conventional 95% level (p = .05 or lower; α = .05, two-tailed).
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SECTION 3: RESULTS

3.1 Demographics
Of the 623 P.R.I.D.E. Alliance students who were emailed the survey link, 155 were
recruited for this study. The majority of the participants were female (72.3%), white (59.1%),
single or never married (77.4%), college seniors (29.9%), and between the ages of 18 and 21
(69.2%). The average age was 21.2 years (SD = 3.2; range = 18 to 46). Approximately one-third
of participants self-identified as homosexual (33.6%), followed by bisexual (29.2%) and
heterosexual (27.0%). The majority of participants are not considering a career in a healthrelated field (60.3%) and had health insurance (82.5%) (Table 1).

Table 1. Sample Demographic Characteristics
n (%)a
Gender (n=137)
Female
Male
MTF Transgender
FTM Transgender
Other

99 (72.3)
32 (23.4)
2 (1.5)
1 ( .7)
3 (2.2)

Ethnic identity (n=137)
White
Hispanic or Latino
More than one race
Black or African American
Asian
American Indian or Alaska Native
Other
Prefer not to answer

59.1 (81)
20 (14.6)
15 (10.9)
13 (9.5)
4 (2.9)
1 (0.7)
1 (0.7)
2 (1.5)
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Table 1. Sample Demographic Characteristics (continued)
n (%)a

a

Sexual Orientation (n=137)
Heterosexual
Homosexual
Bisexual
Questioning
Other

37 (27.0)
46 (33.6)
40 (29.2)
9 (6.6)
5 (3.6)

Current Relationship Status (n=137)
Single or Never Married
Living with a Domestic Partner
Married
Divorced or Separated
Other

106 (77.4)
19 (13.9)
1 (0.7)
2 (1.5)
9 (6.6)

Health Insurance (n=137)
Yes
No
Don‟t Know/ Not Sure
Prefer not to answer

113 (82.5)
21 (15.3)
2 (1.5)
1 (0.7)

Age (n=130)
18-21
22-25
26+

90 (69.2)
29 (22.3)
11 (8.5)

College Level (n=137)
Freshman
Sophomore
Junior
Senior
Graduate Student

25 (18.2)
29 (21.2)
34 (24.8)
41 (29.9)
8 (5.8)

Considering Career in Health-Related Field (n=136)
Yes
No
Don‟t Know/ Undecided

48 (35.3)
82 (60.3)
6 (4.4)

College Major (n=137)
Science
Liberal Arts
Business
History
Social Sciences
Education
Other

25 (18.2)
21 (15.3)
12 (8.8)
4 (2.9)
29 (21.2)
7 (5.1)
39 (28.5)

Percentages may not add up to 100 due to rounding error and/or missing data.
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3.2 HPV Knowledge
Almost all participants indicated that they had heard of HPV (95.5%). In addition, the
majority of participants correctly answered more than half of the items evaluating HPV-related
knowledge, with the greatest portion of participants answering 51-75% of the items correctly
(Table 3).
Three items most frequently answered correctly included: “You can always tell when
someone has HPV,” “You can have HPV without knowing it,” and “HPV can cause cervical
cancer,” by 93.4%, 95.6%, and 95.6% of participants, respectively. Items that participants were
least likely to correctly answer included: “Most HPV infections clear on their own,” “Females
who have been diagnosed with HPV infection should not be given the HPV vaccine,” and “A
„complete STD screen‟ includes testing for HPV,” by 20.6%, 31.1%, and 30.4% of participants,
respectively.
With respect to perceived LGBT risk of HPV infection, the majority of participants
answered correctly that there were HPV posed health risks for gay men (76.3%) and lesbians
(88.1%). The majority of participants (52.6%) either were not sure or incorrectly answered that
lesbians were at a much lower risk for getting HPV than women who have sex with men (Table
2).
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Table 2. HPV Knowledge
Statement
a. HPV can cause HIV/AIDS. False (n=136)
b. You can always tell when someone has HPV.
False (n=136)
c. HPV can cause abnormal Pap smears/ Pap tests.
True (n=136)
d. Only women get HPV. False (n=136)
e. HPV can cause herpes. False (n=136)
f. HPV can cause genital warts. True (n=136)
g. You can have HPV without knowing it. True
(n=136)
h. HPV is a sexually transmitted infection (STI) or
sexually transmitted disease (STD). True
(n=136)
i. HPV can cause cervical cancer. True (n=136)
j. HPV can cause oral cancer. True (n=136)
k. HPV can cause anal cancer. True (n=136)
l. Antibiotics can cure HPV. False (n=136)
m. HPV is rare. False (n=136)
n. Condoms fully protect against HPV. False
(n=136)
o. Most HPV infections clear on their own.
True (n=136)
p. The HPV vaccine protects against all HPV
infections. False (n=135)
q. At least 50% of sexually active men and women
get HPV at some point in their lives. True
(n=135)
r. HPV can be transmitted through oral sex.
True (n=134)
s. Some typical symptoms of HPV include painful
sores and discharge. False (n=135)
t. Only women can get vaccinated against HPV.
False (n=135)
u. Females who have been diagnosed with HPV
infection should not be given the HPV vaccine.
False (n=135)
v. A “complete STD screen” includes testing for
HPV. False (n=135)
w. There are no health risks of HPV for gay men.
False (n=135)
x. There are no health risks of HPV for lesbians.
False (n=135)
y. Lesbians are at a much lower risk for getting
HPV than women who have sex with men.
False (n=135)
a

True
n (%)a

False
n (%)a

Not Sure/Don’t Know
n (%)a

12 (8.8)
0 (0.0)

99 (72.8)
127 (93.4)

25 (18.4)
9 (6.6)

94 (69.1)

11 (8.1)

31 (22.8)

13 (9.6)
34 (25.0)
87 (64.0)
130 (95.6)

111 (81.6)
69 (50.7
20 (14.7)
3 (2.2)

12 (8.8)
33 (24.3)
29 (21.3)
3 (2.2)

119 (87.5)

6 (4.4)

11 (8.1)

130 (95.6)
58 (42.6)
57 (41.9)
10 (7.4)
9 (6.6)
17 (12.5)

2 (1.5)
32 (23.5)
30 (22.1)
97 (71.3)
112 (82.4)
93 (68.4)

4 (2.9)
46 (33.8)
49 (36.0)
29 (21.3)
15 (11.0)
26 (19.1)

28 (20.6)

88 (64.7)

20 (14.7)

13 (9.6)

102 (75.6)

20 (14.8)

73 (54.1)

11 (8.1)

51 (37.8)

84 (62.7)

13 (9.7)

37 (27.6)

68 (50.4)

26 (19.3)

41 (30.4)

40 (29.6)

68 (50.4)

27 (20.0)

32 (23.7)

42 (31.1)

61 (45.2)

49 (36.3)

41 (30.4)

45 (33.3)

5 (3.7)

103 (76.3)

27 (20.0)

2 (1.5)

119 (88.1)

14 (10.4)

27 (20.0)

64 (47.4)

44 (32.6)

Percentages may not add up to 100 due to rounding error and/or missing data.
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Table 3. HPV Knowledge Scores
% of Questions Answered Correctly

# Answered Correctly

Frequency (n=134)

0-25%
26-50%

0-5
6-11

6
37

51-75%
76-100%

12-16
17-22

49
42

3.3 Sexual Health Behaviors
The majority of participants indicated that they were sexually experienced (77.6%) with
both males and females (38.4%) and have had one to five sexual partners (55.4%). Slightly less
than half of female respondents reported ever having a cervical Pap test (43.3%), with two-thirds
(66.1%) have had a cervical Pap test within the past 12 months by a physician, and 72.6% have
not had an abnormal Pap test result.
The vast majority of participants indicated they had not heard of (79.4%) or had an anal
Pap test (98.6%), and the main reason they have not gotten an anal Pap test is that they did not
know enough about it (50.7%).
The majority of participants reported no prior diagnosis of HPV infection or genital warts
(89.4%), and out of those who had been diagnosed, the majority reported having heard of HPV
or genital warts prior to their diagnosis. Approximately two thirds of participants did not report
having a close friend or family member diagnosed with HPV infection or genital warts (64.1%).
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Among those reporting a close friend or family member diagnosed with HPV or genital warts,
the majority of participants indicated that they had heard of HPV or genital warts prior to
learning of their friend or family member‟s diagnosis.
Slightly more than half of participants reported using condoms (55.6%) as a safer sex
barrier method (i.e., male condom, female condom, dental dam). Among those engaging in
sexual activity the most common reason for not using a safer sex barrier method was “they just
don‟t feel the same.” While the majority of participants reported asking their sexual partner(s) if
they had been tested for STIs/STDs (68.5%), among those who did not ask the main reasons
selected were “my partner and I are in a monogamous relationship” (30.9%), and “I‟m
embarrassed to ask” (27.3%) (Table 4).

Table 4. Sexual Health Behaviors
n (%)a
Sexually experienced (have had vaginal, anal, or oral sex) (n=143)
Yes
No
Don‟t Know/ Not sure

111 (77.6)
30 (21.0)
2 (1.4)

Sexually experienced with: (n=112)
Males
Females
Both

42 (37.5)
27 (24.1)
43 (38.4)

Number of sexual partners (n=112)
1-5
6-10
11-15
16-20
21-25
26-30
>30

62 (55.4)
23 (20.5)
9 (8.0)
4 (3.6)
4 (3.6)
2 (1.8)
8 (7.1)
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Table 4. Sexual Health Behaviors (continued)
n (%)a
Have had cervical Pap test/ Pap smear (n=141)
Yes
No
Don‟t Know/Not Sure
Not applicable

61 (43.3)
58 (41.1)
2 (1.4)
20 (14.2)

Length since last cervical Pap test/ Pap smear (n=62)
Less than 12 months ago
1-2 years ago
2-3 years ago
Don‟t Know/Not Sure

41 (66.1)
16 (25.8)
3 (4.8)
2 (3.2)

Have had abnormal Pap test result (n=62)
Yes
No

17 (27.4)
45 (72.6)

How often see physician for a Pap test result (n=62)
Once every 6 months
Once a year
Once every 2 years
Once every 4 of more years
Don‟t Know/ Not Sure
Not applicable
Other

5 (8.1)
39 (62.9)
7 (11.3)
1 (1.6)
5 (8.1)
2 (3.2)
3 (4.8)

Heard of anal Pap test or anal Pap smear (n=141)
Yes
No
Don‟t Know/Not Sure

27 (19.1)
112 (79.4)
2 (1.4)

Had anal Pap test (n=142)
Yes
No

2 (1.4)
140 (98.6)

Most recent anal Pap test (n=2)
Less than 12 months ago
Don‟t Know/ Not sure

1 (50.0)
1 (50.0)
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Table 4. Sexual Health Behaviors (continued)
n (%)a
Reasons for NOT getting an anal Pap test (n=136)
I don‟t know enough about it
Asking for the test or getting it might be embarrassing
It might hurt
Test might not be accurate
Test costs too much
I don‟t have transportation to get to doctor‟s office
I don‟t want this information in my medical chart
Not applicable
Other

69 (50.7)
44 (32.4)
32 (23.5)
4 (2.9)
56 (41.2)
11 (8.1)
6 (4.4)
29 (21.3)
14 (10.3)

Diagnosed with HPV/genital warts (n=142)
Yes
No
Don‟t Know/ Not sure

12 (8.5)
127 (89.4)
3 (2.1)

Heard of HPV/genital warts before being diagnosed with it (n=12)
Yes
No
Don‟t Know/ Not sure

9 (75.0)
2 (16.7)
1 (8.3)

Close friend/ family member diagnosed with HPV/genital warts (n=142)
Yes
No
Don‟t Know/ Not sure

31 (21.8)
91 (64.1)
20 (14.1)

Heard of HPV/genital warts before close friend/ family member diagnosed with it (n=31)
Yes
No
Don‟t Know/ Not sure

26 (83.9)
4 (12.9)
1 (3.2)

Regularly practice the following safer sex methods (n=133)
Condoms (on penis or sex toys)
Gloves (for vaginal/anal sex)
Dental dams (for oral sex)
Change fingers/hand between vagina/anus
Not applicable
Other

74 (55.6)
4 (3.0)
4 (3.0)
23 (17.3)
49 (36.8)
8 (6.0)
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Table 4. Sexual Health Behaviors (continued)
n (%)a
Why don‟t you and partner use male condoms (n=88)
They are unnecessary
They are annoying
They just don‟t feel the same
I don‟t think about wearing them
I am embarrassed to suggest wearing them
I don‟ t have access to them
They are too expensive
I do not engage in sexual activity that requires a male condom
Other

a

13 (14.8)
8 (9.1)
17 (19.3)
6 (6.8)
3 (3.4)
1 (1.1)
1 (1.1)
54 (61.4)
15 (17.0)

Why don‟t you and partner use female condoms or dental dams (n=126)
They are unnecessary
They are annoying
They just don‟t feel the same
I don‟t think about wearing them
I am embarrassed to purchase them
I am embarrassed to suggest wearing them
I don‟t know where to find them
I have never heard of them
I don‟ t have access to them
They are too expensive
I do not engage in sexual activity that requires a female condom or dental dam
Other

29 (23.0)
16 (12.7)
11 (8.7)
22 (17.5)
2 (1.6)
6 (4.8)
15 (11.9)
6 (4.8)
10 (7.9)
6 (4.8)
54 (42.9)
18 (14.3)

Ask sexual partner(s) if they have been tested for STIs/STDs (n=127)
Yes
No
Sometimes

87 (68.5)
23 (18.1)
18 (13.4)

Reasons why don‟t ask sexual partner(s) if they have been tested for STIs/STDs (n=55)
I don‟t think about it
I use condoms
I‟m embarrassed to ask
I trust my partner(s)
My partner and I are in a monogamous relationship
I haven‟t been tested myself
Not applicable
Other

8 (14.5)
9 (16.4)
15 (27.3)
12 (21.8)
17 (30.9)
9 (16.4)
19 (34.5)
5 (9.1)

Percentages may not add up to 100 due to rounding error and/or missing data.
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3.4 HPV Vaccine
While almost all participants indicated having heard of the HPV vaccine (96.5%), the
majority reported not having received the vaccine (62.7%). Among those who had not initiated
HPV vaccination, half reported that they were uncertain about future intention to get the HPV
vaccine. The main barriers to vaccination included cost (41.6%) and perception that the vaccine
was too new (31.5%) (Table 5).

Table 5. HPV Vaccine
n (%)a
Heard of HPV vaccine (n=142)
Yes
No
Don‟t Know/ Not sure

137 (96.5)
4 (2.8)
1 (0.7)

Received the HPV vaccine (n=142)
Yes
No
Don‟t Know/ Not Sure

50 (35.2)
89 (62.7)
3 (2.1)

Number of shots received in the HPV vaccine series (n=50)
1
2
3
Don‟t Know/Not sure
Plan on getting the HPV vaccine if already haven‟t gotten it (n=92)
Yes
No
Don‟t Know/ Not Sure
Not applicable

5 (10)
6 (12)
36 (72)
3 (6)

13 (14.1)
26 (28.3)
46 (50.0)
7 (7.6)
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Table 5. HPV Vaccine (continued)
n (%)a
Reasons why haven‟t gotten the HPV vaccine (n=89)
Cost
I did not think about it
I had not heard of the HPV vaccine
I am not at risk for HPV
I have already had HPV
I don‟t believe in vaccines
I don‟t like injections
Vaccine is too new
I don‟t want my parents to know I‟m sexually active
I am not eligible to receive the vaccine
Other
a

37 (41.6)
25 (28.1)
2 (2.2)
15 (16.9)
1 (1.1)
4 (4.5)
10 (11.2)
28 (31.5)
6 (6.7)
7 (7.9)
16 (18.0)

Percentages may not add up to 100 due to rounding error and/or missing data.

3.5 Attitudes, Beliefs, and Perceptions
Over half of participants disagreed or strongly disagreed with the susceptibility items (“It
is extremely likely that I will get HPV in my lifetime;” “My current behaviors put me at risk for
HPV”), indicating that they did not perceive themselves to be at risk for contracting HPV. Over
80% of participants agreed or strongly agreed that HPV, cervical cancer, and penile cancer were
serious conditions. Several facilitators of vaccination were highlighted, with the majority of
participants agreeing or strongly agreeing with the following statements: “Getting the HPV
vaccine could save my life;” “Knowing that HPV affects people like me would encourage me to
get the HPV vaccine;” and “Knowing more about HPV would encourage me to get the HPV
vaccine.” Over half of participants disagreed or strongly disagreed that cost, fear of needles, and
vaccine efficacy were barriers to vaccination. Regarding normative beliefs, roughly half of
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participants neither agreed nor disagreed that mother, grandmother, and friend approval of the
HPV vaccine would directly translate to personal approval of the vaccine (see Table 6).

Table 6. Attitudes, Beliefs, and Perceptions

Statements
a. It is extremely likely that I will get
HPV in my lifetime. (n=137)
(susceptibility)
b. My current behaviors put me at risk
for HPV. (n=138) (susceptibility)
c. HPV is a serious infection. (n=137)
(severity)
d. Cervical cancer is a serious disease.
(n=138) (severity)
e. Cancer of the penis is a serious
disease. (n=136) (severity)
f. I get scared when I think of getting
HPV. (n=138) (barriers)
g. I couldn‟t afford to get the HPV
vaccine. (n=138) (barriers)
h. I would not get the HPV vaccine
because I am afraid of needles.
(n=138) (barriers)
i. I don‟t think vaccines work.
(n=138) (barriers)
j. Getting the HPV vaccine could save
my life. (n=138) (facilitators)
k. Knowing that HPV affects people
like me would encourage me to get
the HPV vaccine. (n=138)
(facilitators)
l. Knowing more about HPV would
encourage me to get the HPV
vaccine. (n=138) (facilitators)
m. If my mother approved of the HPV
vaccine then I would approve of it
also. (n=138) (normative beliefs)
n. If my grandmother approved of the
HPV vaccine then I would approve
of it also. (n=138) (normative beliefs)
o. If my friends approved of the HPV
vaccine then I would approve of it
also. (n=138) (normative beliefs)
a

Disagree
N (%)a

Neither
Agree nor
Disagree
n (%)a

Agree
n (%)a

Strongly
Agree
n (%)a

31 (22.6)

41 (29.9)

39 (28.5)

12 (8.8)

14 (10.2)

61 (44.2)

36 (26.1)

21 (15.2)

15 (10.9)

5 (3.6)

3 (2.2)

3 (2.2)

15 (10.9)

55 (40.1)

61 (44.5)

3 (2.2)

1 (.07)

3 (2.2)

16 (11.6)

115 (88.3)

3 (2.2)

2 (1.5)

8 (5.9)

13 (9.6)

110 (80.9)

7 (5.1)

19 (13.8)

38 (27.5)

46 (33.3)

28 (20.3)

37 (26.8)

39 (28.3)

36 (26.1)

21 (15.2)

5 (3.6)

86 (62.3)

28 (20.3)

15 (10.9)

8 (5.7)

1 (0.7)

70 (50.7)

40 (29.0)

21 (15.2)

3 (2.2)

4 (2.9)

5 (3.6)

3 (2.2)

40 (29.0)

64 (46.4)

26 (18.8)

7 (5.1)

4 (2.9)

28 (20.3)

74 (53.6)

25 (18.1)

5 (3.6)

7 (5.1)

34 (24.6)

62 (44.9)

30 (21.7)

10 (7.2)

17 (12.3)

66 (47.8)

31 (22.5)

14 (10.1)

13 (9.4)

20 (14.5)

69 (50.0)

25 (18.1)

11 (8.0)

10 (7.2)

15 (11.6)

80 (58.0)

22 (15.9)

10 (7.2)

Strongly
Disagree
n (%)a

Percentages may not add up to 100 due to rounding error and/or missing data.
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3.6 Health Care Experiences
Slightly more than half of participants reported believing their doctor to be heterosexual
(73.5%) and female (56.6%). Additionally, 41.6% indicated that they believed their doctor knew
their sexual orientation because they disclosed it without being asked (47.4%). Among those
that did not disclosing their sexual orientation, 41.3% they reported that they did not find it
necessary to do so. The majority of participants (84.2%) felt their doctor to be very comfortable
with their sexual orientation and with 40.1% believing that it somewhat important that their
doctor know their sexual orientation.
The majority of participants believed that their doctor knew their identity (83.1%)
because he or she probably assumed it (81.8%). The majority reported that their doctor was very
comfortable with their gender identity (94.5%), and one-third felt it was very important that their
doctor knew their gender identity. The most commonly cited reason for not disclosing gender
identity was that participants felt it was unnecessary.
Approximately two-thirds of participants reported feeling comfortable discussing sexual
health with their doctor (67.9%). Almost half said that their doctor talked to them about HPV
(48.1%), and more than half said their doctor talked to them about risks of other STIs/STDs
(63.7%). The majority of participants said their doctor talked to them about the HPV vaccine
(52.2%), and out of those, 88.7% said their doctor recommended the vaccine (see Table 7).
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Table 7. Health Care Experiences
n (%)a
Doctor‟s gender (n=136)
Female
Male
MTF Transgender
Don‟t Know/ Not Sure

77 (56.6)
46 (33.8)
1 (0.7)
12 (8.8)

Doctor‟s sexual orientation (n=136)
Gay/Lesbian/Homosexual
Bisexual
Straight/Heterosexual
Don‟t Know/ Not Sure

2 (1.5)
1 (0.7)
100 (73.5)
33 (24.3)

Believe that your doctor knows your sexual orientation (n=137)
Yes
No
Don‟t Know/Not sure

57 (41.6)
53 (38.7)
27 (19.7)

How does your doctor know your sexual orientation (n=57)
He or she probably assumes it
Someone else told him or her
I disclosed it without being asked
I disclosed it because my doctor asked me

15 (26.3)
2 (3.5)
27 (47.4)
13 (22.8)

Comfort of doctor with your sexual orientation (n=57)
Very comfortable
Somewhat comfortable

48 (84.2)
9 (15.8)

Importance that your doctor knows about your sexual orientation (n=137)
Very important
Somewhat important
Somewhat unimportant
Not at all important

36 (26.3)
55 (40.1)
16 (11.7)
30 (21.9)

Reasons why you didn‟t disclose your sexual orientation (n=126)
Not necessary
Nervous
He/She wouldn‟t agree/understand
Don‟t want my parents to know
Uncertain of my sexual orientation
Not applicable
Other

52 (41.3)
3 (2.4)
3 (2.4)
8 (6.3)
9 (7.1)
42 (33.3)
9 (7.1)
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Table 7. Health Care Experiences (continued)
n (%)a
Believe that your doctor knows your gender identity (n=136)
Yes
No
Don‟t Know/Not sure

113 (83.1)
9 (6.6)
10.3 (14)

How does your doctor know your gender identity (n=110)
He or she probably assumes it
Someone else told him or her
I disclosed it without being asked
I disclosed it because my doctor asked me

90 (81.8)
2 (1.8)
13 (11.8)
5 (4.5)

Comfort of doctor with your gender identity (n=109)
Very comfortable
Somewhat comfortable
Somewhat uncomfortable

103 (94.5)
5 (4.6)
1 (0.9)

Importance that your doctor knows about your gender identity (n=132)
Very important
Somewhat important
Somewhat unimportant
Not at all important

44 (33.3)
39 (29.5)
16 (12.1)
33 (25.0)

Reasons why you didn‟t disclose your gender identity (n=125)
Not necessary
Nervous
He/She wouldn‟t agree/understand
Don‟t want my parents to know
Uncertain of my sexual orientation
Not applicable
Other

51 (40.8)
1 (0.8)
1 (0.8)
2 (1.6)
4 (3.2)
61 (48.8)
5 (4.0)

Comfort discussing sexual health with doctor (n=137)
Very comfortable
Somewhat comfortable
Somewhat uncomfortable
Not at all comfortable

51 (37.2)
42 (30.7)
32 (23.4)
13 (9.5)

Doctor talked about HPV (n=135)
Yes
No
Don‟t Know/ Not Sure

65 (48.1)
61 (45.2)
9 (6.2)

Doctor talked about risks of other STIs/STDs (n=135)
Yes
No
Don‟t Know/ Not Sure

86 (63.7)
42 (31.1)
7 (5.2)
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Table 7. Health Care Experiences (continued)
n (%)a

a

Doctor talked about HPV vaccine (n=136)
Yes
No
Don‟t Know/ Not Sure

71 (52.2)
58 (42.6)
7 (5.1)

Doctor recommended the HPV vaccine (n=71)
Yes
No
Don‟t Know/ Not Sure

63 (88.7)
4 (5.6)
4 (5.6)

Percentages may not add up to 100 due to rounding error and/or missing data.

SECTION 4: DISCUSSION

4.1 Overview
This study helps to fill gaps in the HPV and HPV vaccine literature by exploring and
describing the degree of knowledge; attitudes, beliefs, and perceptions; and sexual health
behaviors related to HPV and HPV vaccination among LGBT students and Allies. Although
many studies have surveyed students about HPV and HPV vaccination, to our knowledge no
other studies have explored this topic in an LGBT student population. The results of this study
gave insight into participant knowledge, participant attitudes, and participant behaviors
concerning HPV and the HPV vaccine.

4.2 Participant Knowledge
Regarding knowledge, almost all participants (95.5%) had heard of HPV, and the overall
knowledge score was comparable to other studies of HPV knowledge among college students
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(e.g., (Bendik, Mayo, & Parker, 2011; Bynum, 2009). On average, the participants answered
approximately 59% of the questions correctly.
Interestingly, almost all participants (95.6% and 93.5%, respectively) answered correctly
that “You can have HPV without knowing it” and “You can‟t always tell when someone has
HPV,” yet 50.4% of respondents falsely thought that “some typical symptoms of HPV include
painful sores and discharge.” Also, only 20.6% of participants knew that most HPV infections
clear on their own. Almost all participants (95.6%) knew that HPV can cause cervical cancer, yet
fewer than half of participants knew that HPV can cause oral and anal cancer. These results
indicate a high general knowledge of HPV, but when it comes to specific details, participants
seem to be less clear on the facts. These findings are consistent with previous research. For
example, Bendik and colleagues (2011) demonstrated that most college women tended to know
that HPV can be asymptomatic and may cause cervical cancer, yet few knew the details of HPV,
including the consequences of HPV and its mode of transmission. While the results suggest that
overall respondents were aware of HPV related risks to the gay and lesbian community, they
were less clear about the magnitude of the risk, with over half of participants incorrectly
responding the lesbians are at much lower risk for HPV infection than heterosexual females.
Risks for the lesbian community are similar to heterosexual women. The vast majority of
women who have sex with women (WSW) have had sex with men as well (Information, 2007).
HPV has also shown to be transmissible through sex between women, as it can be passed on
through oral sex and genital-to-genital contact, and cervical cancer has been seen in women who
have had sex exclusively with women (CDC, 2009; Information, 2007). Even though it is
possible that the risk of HPV infection is slightly lower for women who exclusively have sex
with women than in exclusively heterosexual women, WSW are less likely to utilize preventive
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health services, such as Pap screenings, increasing their risk of HPV-related diseases
(Information, 2007; Power et al., 2009).
HPV is very common in gay and bisexual men. One study detected 61% of HIV-negative
and 93% of HIV-positive gay and bisexual men with HPV (Palefsky et al., 2000). Gay and
bisexual men are at an increased risk for anal cancer; the incidence of anal cancer in
homosexually active men is actually higher than that for cervical cancer in women (Palefsky et
al., 2000).
Additionally, the current study demonstrates that there is limited awareness about the role
of HPV in cancers beyond cervical cancer. In Pitts‟ study of gay men‟s knowledge of HPV and
anal cancer screening, it was also shown that participants knew very little about anal cancer and
HPV (2007).
Given current studies that have firmly established the link between HPV infection and
oral and anal cancers (Daling et al., 2004; Gillison et al., 2000; Smith et al., 1998), education
about these risks in the LGBT community is critical. In addition, most participants are unaware
of screening and early detection methods for these other HPV associated cancers. In Pitts‟ study
of gay men‟s knowledge of HPV and anal cancer screening, a little over half (55.1%) of
participants had never heard of an anal pap smear, compared to well over half (79.4%) of the
participants in our study (2007).
There are currently no standardized screening guidelines for anal cancers. Some
clinicians recommend yearly anal Pap smears for MSM, and in particular HIV-positive MSM
(Network, 2011; Rosa-Cunha et al., 2011). The most recent recommendations from the CDC
state that “Anal cytology screening of HIV-infected men who have sex with men . . . might
become useful preventive measures. However, studies of screening and treatment programs for
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anal HSILs need to be implemented before recommendations for anal cytology screening can be
made”(Prevention, 2002). As guidelines become more established for at risk groups (e.g.,
homosexual men), our study suggest that lack of knowledge may be one barrier to uptake.
Importantly, only half of respondents were aware that HPV vaccination was also
available to men. The FDA approved the use of Gardasil in males aged 9 to 26 years for
prevention of genital warts in October 2009 and for the prevention of anal cancer in December
2010 (FDA, 2009). Previous research has indicated that anal cancer is prevalent in about 57% of
HIV-negative MSMs and that Gardasil may prevent as much as 80% of anal carcinomas (ChinHong et al., 2004; Hoots, Palefsky, Pimenta, & Smith, 2009). Furthermore, in addition to health
consequences, genital warts are linked to psychological and emotional effects among men (Maw,
Reitano, & Roy, 1998). Increasing knowledge about the availability of HPV vaccination for men
may influence uptake, thereby decreasing incidence of genital warts and anal cancer.

4.3 Participant Attitudes
By evaluating participant attitudes, our study identified important attitudinal beliefs,
barriers, facilitators, and normative beliefs that may influence uptake of HPV vaccination among
LGBT students.
In terms of perceived susceptibility, overall participants did not perceive themselves to be
at risk for contracting HPV. The majority of participants agreed that their current behaviors do
not put them at risk for HPV, yet most are sexually active, and although most use condoms,
condoms do not fully protect against HPV. This ties back into the lack of knowledge about the
specifics of HPV, as only 68.4% of people knew that condoms do not fully protect against HPV.
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From the knowledge section, most correctly answered that more than 50% of sexually active
men and women will get HPV at some point in their lives, yet the majority of participants
disagreed that “It is extremely likely that I will get HPV in my lifetime.” There seems to be a
disconnect between what they know is true and how they apply that information to themselves.
The participants seem to perceive themselves as having a more positive outcome (in this case,
being at a lower risk to get HPV) than others in the similar circumstances, which is known as
“unrealistic optimism” (Clarke, Lovegrove, Williams, & Machperson, 2000). Other studies have
found that sexually active adolescents display a strong optimistic bias about avoiding STDs as
well (Cohn, MacFarlane, Yanez, & Imai, 1995; Whaley, 2000).
In terms of perceived severity, the majority of participants agreed that HPV and HPVassociated diseases (e.g. cervical cancer and penile cancer) were serious conditions. In terms of
facilitators, participants agreed that knowing more about HPV would encourage them to get the
HPV vaccine. In Bendik‟s HPV study surveying college women, both knowledge and an
increased perceived severity of HPV and cervical cancer were associated with receiving the
vaccine (2011). Given the previous research on knowledge and vaccine uptake, perhaps
increasing HPV knowledge in this population could increase vaccine uptake.
Another facilitator that participants agreed with was “knowing that HPV affects people
like me would encourage me to get the HPV vaccine.” There is not much literature about HPV
specifically directed towards the LGBT community, as most educational material is geared
towards heterosexual individuals. Adding educational material about HPV specifically for the
LGBT population could be beneficial for vaccine uptake as well.
The main barrier was getting scared when thinking about HPV. The majority of
participants disagreed that cost was a barrier (“they couldn‟t afford to get the HPV vaccine”), yet
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out of the participants who hadn‟t gotten the HPV vaccine, cost was reported to be one of the
main reasons why. In Bendik‟s study, out of the participants who had not yet received the
vaccine, almost 20% indicated that finding a way to pay for the vaccine would motivate them to
receive the vaccine the most (2011).
In terms of normative beliefs, the participants were neutral as to whether mother,
grandmother, and friend approval of the HPV vaccine would cause them to approve of it also.
Yet, results from Bendik‟s study showed that those who had parent approval, as well as those
who had friend approval, were more likely to receive the vaccine (2011).

4.4 Participant Behaviors
Participants‟ behaviors and practices also bring up some interesting issues. A total of
35.2% of participants have received the HPV vaccine. This is consistent with a previous study by
Bendik and colleagues concerning HPV vaccination among college students in which
approximately 37.7% of students received the HPV vaccine (Bendik et al., 2011). Yet, in
Bendik‟s study, approximately 50% of students who had not yet received the HPV vaccine
intended to do so, compared to 14.1% of students in this study (Bendik et al., 2011). Although
30% chose to get the HPV vaccine, a main concern is that over twice as many are not. As
previously discussed, participants agreed that knowing more about HPV would encourage them
to get the HPV vaccine, so the extra information could influence some of those in the “not sure”
category. Also, doctor recommendation could encourage some to get the HPV vaccine (Reiter et
al., 2010; Rosenthal et al., 2011). In this study, over half of participants reported talking to their
doctor about the HPV vaccine, and out of those, 88.7% reported that their doctor recommended
the HPV vaccine. Out of the 50 participants who reported receiving the HPV vaccine, 42 of
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those also reported their doctor recommending the HPV vaccine to them (data not shown), which
may provide further evidence for the importance of physician recommendation.
Some safer sex barrier methods were much more popular than others. Condom use was
reported by 55.6% of participants, whereas only 3% use dental dams and gloves. These results
are consistent with Power and colleagues‟ (2009) study, which also found that dental dams and
gloves were the least popular safer sex method barrier method. It is also apparent that many
lesbians do not regularly practice any form of safer sex, which is consistent with several previous
studies (Cox & McNair, 2009; Hyde, Comfort, Brown, McManus, & Howat, 2007; Power et al.,
2009; Richters, Song, G., Clayton, & Turner, 2005). Regarding dental dams, 11.9% said they
did not know where to find them, 4.8% had never heard of them, and 7.9% said they did not have
access to them, although the USF Student Health Center provides free condoms and dental dams
to students; however, the male condoms are visibly placed on the counter at the front desk for
students to take, whereas students have to specifically ask for female condoms/dental dams.
Having to inquire for female condoms/dental dams may be embarrassing and could impede
students from asking. Moreover, free male condoms from the health center are advertised
around campus, whereas the free female condoms and dental dams are not typically advertised.
These findings have important implications for interventions designed to increase use of safer
sex methods. Such interventions could focus on increasing awareness of the availability of
female condoms and dental dams on campus. The majority of applicable participants (68.5%)
ask their sexual partners if they have been tested for STIs/STDs, which could also be why
participants feel at such a low risk for HPV because they have asked their participants if they
have been tested. However, HPV is not included in a “complete STD screen,” which only 30.4%
of participants knew and correctly answered in the knowledge section, and HPV does not usually
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show any signs or symptoms, therefore, the majority of people do not even know they have it
(CDC, 2009).

SECTION 5: CONCLUSION

5.1 Findings and Implications
There is a need to gather knowledge, attitudes, and behaviors regarding HPV and the
HPV vaccine in order to understand, and eventually design interventions to remove barriers to
HPV vaccine uptake in a LGBT college student population. Regarding HPV knowledge, while
almost all of the college students surveyed indicated they had heard of HPV, many demonstrated
a suboptimal level of knowledge about HPV and the HPV vaccine. This suggests this population
of students understands the general concept, but is less clear on the specifics. It is possible this
reduced understanding is based on the information promoted through media coverage, which
could also explain why knowledge of HPV health risks specific to the LGBT community is low.
Regarding attitudes, participants agreed HPV is serious and very common, yet they do not
believe they are at high risk. Also, they agreed that knowing that HPV affects people like them
would encourage them to get the vaccine. Therefore, personalizing HPV, which could include
educational material directed at an LGBT-specific population, could help them understand their
risks and encourage them to get the HPV vaccine. In terms of behaviors, the majority of
participants have not gotten the vaccine, yet they reported that knowing more information about
HPV would encourage them to get the vaccine, so increasing knowledge and education could
increase vaccine uptake. Also, the majority of participants reported using male condoms,
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whereas other safer sex methods (i.e., dental dams and gloves) were much less common. This
could also be due to the lack of sexual health education specifically for women who have sex
with women.
By conducting this exploratory survey, we were able to identify and understand factors
associated with preventive sexual health measures (i.e., HPV vaccination), which may serve as
an important step toward developing and planning interventions to promote these measures in the
future. Knowledge appears to be a major barrier associated with pursuing these preventative
measures. More LGBT-specific education related not only to HPV, but sexual health in general,
could increase these preventative measures and benefit the overall health of this population.

5.2 Limitations
While this study provides important information regarding the LGBT community, it must
be considered in light of certain limitations. First, this study was based on self-reported data.
Although the survey was confidential, sexual health is a sensitive topic; therefore, social
desirability bias could have compromised the validity of certain responses. Additionally,
responses could have been subjected to recall bias whereby participants did not accurately recall
their own behaviors. Another limitation was the use of convenience sampling, which may limit
the generalizability of study findings. Also, the sample included a mix of LGBT students and
Allies and therefore did not focus exclusively on LGBT students; however, this mix allows for
the future comparison of responses from heterosexual, bisexual, and homosexual participants.
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APPENDIX B:
STUDENT SURVEY
This survey is being conducted to assess college students’ knowledge, attitudes, and
practices concerning human papillomavirus (HPV) and the HPV vaccine. Do not write
your name or any other type of identifying information. This survey will be kept
confidential.
1. For each question in this survey, please bubble in the appropriate box OR write your
answer in the space provided.
2. Unless the instructions tell you otherwise, please select only one response for each
question.
3. While we would like for you to complete the entire survey, you can skip any question
that you do not wish to answer.
4. If a question does not apply to you, skip it and proceed to the next question.
5. Some answers will ask you to skip to a different question. Please follow the skip
patterns.
Thank you for your input.

Section 1: HPV KNOWLEDGE
1. Have you ever heard of HPV? HPV stands for human papillomavirus.
□ Yes
□ No: Skip to question 3

2. Please indicate whether you think the statement is true or false by marking the
appropriate box.
Statement
a. HPV can cause HIV/AIDS.
b. You can always tell when someone has HPV.
c. HPV can cause abnormal Pap smears/ Pap tests.
d. Only women get HPV.
e. HPV can cause herpes.
f. HPV can cause genital warts.
g. You can have HPV without knowing it.
h. HPV is a sexually transmitted infection (STI) or
sexually transmitted disease (STD).
i. HPV can cause cervical cancer.
j. HPV can cause oral cancer.
k. HPV can cause anal cancer.

True

False

□
□
□
□
□
□
□
□

□
□
□
□
□
□
□
□

Not Sure/
Don’t Know
□
□
□
□
□
□
□
□

□
□
□

□
□
□

□
□
□
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Statement

True

False

l. Antibiotics can cure HPV.
m. HPV is rare.
n. Condoms fully protect against HPV.
o. Most HPV infections clear on their own.
p. The HPV vaccine protects against all HPV
infections.
q. At least 50% of sexually active men and women
get HPV at some point in their lives.
r. HPV can be transmitted through oral sex.
s. Some typical symptoms of HPV include painful
sores and discharge.
t. Only women can get vaccinated against HPV.
u. Females who have been diagnosed with HPV
infection should not be given the HPV vaccine.
v. A “complete STD screen” includes testing for
HPV.
w. There are no health risks of HPV for gay men.
x. There are no health risks of HPV for lesbians.
y. Lesbians are at a much lower risk for getting
HPV than women who have sex with men.

□
□
□
□
□

□
□
□
□
□

Not Sure/
Don’t Know
□
□
□
□
□

□

□

□

□
□

□
□

□
□

□
□

□
□

□
□

□

□

□

□
□
□

□
□
□

□
□
□

Section 2: SEXUAL HEALTH BEHAVIORS
Please answer the following questions about your sexual health behaviors to the best of
your ability. If a question does not apply to you, please skip it and move on to the next
question.
3. Are you sexually experienced (have had vaginal, anal, or oral sex)?
□ Yes
□ No (skip to question 6)
□ Don‟t know/Not sure
4. If so, are you sexually experienced with males, females, or both?
□ Males
□ Females
□ Both
5. In your lifetime, with how many different people have you had vaginal, anal, or oral sex?
____________ (please fill in a number)
6. Have you ever had a cervical Pap test (also known as a Pap smear)?
□ Yes
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□ No (skip to question 10)
□ Don‟t know/Not sure (skip to question 10)
□ Not applicable
7. How long has it been since you had your last Pap smear?
□ Less than 12 months ago
□ 1-2 years ago
□ 2-3 years ago
□ 3-5 years ago
□ Don‟t know/Not sure
8. Have you ever had an abnormal Pap test result?
□ Yes
□ No
□ Don‟t know/Not sure
9. Approximately how often do you see a physician for a Pap test?
□ Once every 6 months
□ Once a year
□ Once every two years
□ Once every three years
□ Once every four or more years
□ Other _____________________________________________ (please specify)
□ Don‟t know/Not sure
□ Not applicable
10. Have you ever heard of an anal Pap test or anal Pap smear?
□ Yes
□ No
□ Don‟t know/Not sure
11. Doctors can use an anal Pap test to identify anal cancer. An anal Pap test is when a
doctor collects cells from the anus using a swab (like an extra long Q-tip) and examines
them for changes. An anal Pap test is not the same as a test for anal gonorrhea, a
colonoscopy, or a digital rectal exam.
Have you ever had an anal Pap test?
□ Yes
□ No (skip to question 13)
□ Don‟t know/Not sure (skip to question 13)
12. If you have had an anal Pap test, when was your most recent one?
□ Less than 12 months ago
□ 1-2 years ago
□ 2-3 years ago
□ 3-5 years ago
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□ Don‟t know/Not sure
13. If a local doctor or clinic provided anal Pap tests, what would be your reasons for not
getting one? (Check all that apply)
□ I don‟t know enough about it
□ Asking for test or getting it might be embarrassing
□ It might hurt
□ Test might not be accurate
□ Test costs too much
□ I don‟t have transportation to get to doctor‟s office
□ I don‟t want this information in my medical chart
□ Not applicable
□ Other ___________________________________________ (please specify)
14. Have you ever been diagnosed with HPV or genital warts?
□ Yes
□ No (skip to question 16)
□ Don‟t know/Not sure (skip to question 16)
15. If you answered yes to the previous question, had you ever heard of HPV or genital
warts before you were diagnosed with it?
□ Yes
□ No
□ Not applicable
16. Do you have a close friend/family member that has been diagnosed with HPV or genital
warts?
□ Yes (skip to question 18)
□ No (skip to question 18)
17. If you answered yes to the previous question, had you ever heard of HPV or genital warts
before your close friend/family member was diagnosed with it?
□ Yes
□ No
□ Not applicable
18. Do you regularly (most or all of the time) practice any of the following safer sex
methods? (Check all that apply)
□ Condoms (on penis or sex toys)
□ Gloves (for vaginal/anal sex)
□ Dental dams (for oral sex)
□ Change fingers/hand between vagina/anus
□ Not applicable
□ Other _____________________________________________ (please specify)
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19. If you or your partner do not use male condoms, why? (Check all that apply)
□ They are unnecessary
□ They are annoying
□ They just don‟t feel the same
□ I don‟t think about wearing them
□ I am embarrassed to purchase them
□ I am embarrassed to suggest wearing them
□ I don‟t have access to them
□ They are too expensive
□ I do not engage in sexual activity that requires a male condom
□ Other _____________________________________________ (please specify)
20. If you or your partner do not use female condoms or dental dams, why? (Check all that
apply)
□ They are unnecessary
□ They are annoying
□ They just don‟t feel the same
□ I don‟t think about wearing them
□ I am embarrassed to purchase them
□ I am embarrassed to suggest wearing them
□ I don‟t know where to find them
□ I have never heard of them
□ I don‟t have access to them
□ They are too expensive
□ I do not engage in sexual activity that requires a female condom or dental dam
□ Other _____________________________________________ (please specify)
21. If you are sexually active, do you ask your sexual partner(s) if they have been tested for
sexually transmitted infections (STIs) or sexually transmitted diseases (STDs)?
□ Yes (skip to question 23)
□ No
□ Sometimes
22. If you do not ask your sexual partner(s) if they have been tested for sexually transmitted
infections (STIs) or sexually transmitted diseases (STDs), why not? (Check all that
apply)
□ I don‟t think about it
□ I use condoms
□ I‟m embarrassed to ask
□ I trust my partner(s)
□ My partner and I are in a monogamous relationship
□ I haven‟t been tested myself
□ Not applicable
□ Other _____________________________________________ (please specify)
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Section 3: HPV VACCINE
Please answer the following questions about the HPV vaccine to the best of your ability. If
a question does not apply to you, please skip it and move on to the next question.
23. Before this survey, had you ever heard of the HPV vaccine? This vaccine is also referred
to as the HPV shot, GARDASIL, or CERVARIX.
□ Yes
□ No
□ Don‟t know/Not sure
24. Have you received the HPV vaccine?
□ Yes
□ No (skip to question 26)
□ Don‟t know/Not sure (skip to question 26)
25. How many shots in the series have you received (there are 3 total)?
□ 1
□ 2
□ 3 (all of them)
26. If you haven‟t already gotten the HPV vaccine, do you plan on getting the vaccine?
□ Yes
□ No
□ Don‟t know/Not sure
27. What are some reasons you have not gotten the HPV vaccine? (Check all that apply)
□ Cost
□ I did not think about it
□ I had not heard of the HPV vaccine
□ I am not at risk for HPV
□ I have already had HPV
□ I don‟t believe in vaccines
□ I don‟t like injections
□ Vaccine is too new
□ I don‟t want my parents to know I‟m sexually active
□ I am not eligible to receive the vaccine
□ Other _____________________________________________ (please specify)
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Section 4: ATTITUDES, BELIEFS, AND PERCEPTIONS
28. This section asks about your beliefs and perceptions about HPV and the HPV
vaccine. Please tell us whether you agree or disagree with the following statements
(from “strongly disagree” to “strongly agree”).

a. It is extremely likely that I will get
HPV in my lifetime.
b. My current behaviors put me at risk
for HPV.
c. HPV is a serious infection.
d. Cervical cancer is a serious disease.
e. Cancer of the penis is a serious
disease.
f. I get scared when I think of getting
HPV.
g. I couldn‟t afford to get the HPV
vaccine.
h. I would not get the HPV vaccine
because I am afraid of needles.
i. I don‟t think vaccines work.
j. Getting the HPV vaccine could save my
life.
k. Knowing that HPV affects people like
me would encourage me to get the HPV
vaccine.
l. Knowing more about HPV would
encourage me to get the HPV vaccine.
m. If my mother approved of the HPV
vaccine then I would approve of it also.
n. If my grandmother approved of the HPV
vaccine then I would approve of it also.
o. If my friends approved of the HPV
vaccine then I would approve of it also.

Section 5: HEALTH CARE EXPERIENCES

Agree

Strongly
Agree

□

Neither
Agree
nor
Disagree
□

□

□

□

□

□

□

□

□
□
□

□
□
□

□
□
□

□
□
□

□
□
□

□

□

□

□

□

□

□

□

□

□

□

□

□

□

□

□
□

□
□

□
□

□
□

□
□

□

□

□

□

□

□

□

□

□

□

□

□

□

□

□

□

□

□

□

□

□

□

□

□

□

Strongly
Disagree

Disagree

□
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Please answer the following questions about your doctor, relationship with your doctor,
and health care experiences. By doctor, we are referring to your current primary care
physician, nurse practitioner, or physician assistant who treats your physical health. If you do
not currently have a primary care provider, then please consider your most recent primary care
provider when answering these questions.
29. What is your doctor‟s gender?
□ Female
□ Male
□ MTF (Male to Female) Transgender
□ FTM (Female to Male) Transgender
□ Don‟t know/Not sure
30. Do you think your doctor is:
□ Gay/Lesbian/Homosexual
□ Bisexual
□ Straight/Heterosexual
□ Don‟t know/Not sure
31. Do you believe your doctor knows what your sexual orientation is?
□ Yes
□ No (skip to question 34)
□ Don‟t know/Not sure (skip to question 34)
32. How does your doctor know your sexual orientation?
□ He or she probably assumes it.
□ Someone else told him or her.
□ I disclosed it without being asked.
□ I disclosed it because my doctor asked me.
33. How comfortable does your doctor seem to be with your sexual orientation?
□ Very comfortable
□ Somewhat comfortable
□ Somewhat uncomfortable
□ Not at all comfortable
34. How important do you think it is that your doctor know about your sexual orientation?
□ Very important
□ Somewhat important
□ Somewhat unimportant
□ Not at all important
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35. If you did not disclose your sexual orientation, why not? (Check all that apply)
□ Not necessary
□ Nervous
□ He/She wouldn‟t agree or understand
□ Don't want my parents to know
□ Uncertain of my sexual orientation
□ Not applicable
□ Other ____________________________________________ (please specify)
36. Do you believe your doctor knows what your gender identity is?
□ Yes
□ No (skip to question 39)
□ Don‟t know/Not sure (skip to question 39)
37. How does your doctor know your gender identity?
□ He or she probably assumes it.
□ Someone else told him or her.
□ I disclosed it without being asked.
□ I disclosed it because my doctor asked me.
38. How comfortable does your doctor seem to be with your gender identity?
□ Very comfortable
□ Somewhat comfortable
□ Somewhat uncomfortable
□ Not at all comfortable
39. How important do you think it is that your doctor know about your gender identity?
□ Very important
□ Somewhat important
□ Somewhat important
□ Not at all important
40. If you did not disclose your gender identity, why not? (Check all that apply)
□ Not necessary
□ Nervous
□ He/She wouldn‟t agree or understand
□ Don't want my parents to know
□ Uncertain of my gender identity
□ Not applicable
□ Other ____________________________________________ (please specify)
41. How comfortable are you with discussing sexual health with your doctor?
□ Very comfortable
□ Somewhat comfortable
□ Somewhat uncomfortable
□ Not at all comfortable
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42. Has your doctor ever talked to you about HPV?
□ Yes
□ No
□ Don‟t know/Not sure
43. Has your doctor ever talked to you about risks of other sexually transmitted infections
(STIs) or sexually transmitted diseases (STDs)?
□ Yes
□ No
□ Don‟t know/Not sure
44. Has your doctor ever talked to you about the HPV vaccine?
□ Yes
□ No (skip to question 46)
□ Don‟t know/Not sure (skip to question 46)
45. If yes, did your doctor recommend the vaccine?
□ Yes
□ No
□ Don‟t know/Not sure

Section 6: DEMOGRAPHIC INFORMATION
46. What is your gender?
□ Female
□ Male
□ MTF (Male to Female) Transgender
□ FTM (Female to Male) Transgender
□ Other _____________________________________________ (please specify)
47. What is your ethnic identity?
□ American Indian or Alaska Native
□ Asian
□ Black or African American
□ Hispanic or Latino
□ Native Hawaiian or other Pacific Islander
□ White
□ More than one race
□ Other
□ Prefer not to answer
48. What is your age? ________

49

49. What best describes your major?
□ Science
□ Liberal Arts
□ Business
□ History
□ Social Sciences
□ Math
□ Education
□ Other _____________________________________________ (please specify)
50. Are you considering a career in a health-related field?
□ Yes
□ No
□ Don‟t know/Undecided
51. What is your college level?
□ Freshman (0-29 credit hours)
□ Sophomore (30-59 credit hours)
□ Junior (60-89 credit hours)
□ Senior (90+ credit hours)
□ Graduate Student
52. Which of the following best describes your current relationship status?
□ Single or Never married
□ Living with a Domestic Partner
□ Married
□ Divorced or Separated
□ Widowed
□ Other _____________________________________________ (please specify)
53. Which of the following best describes your sexual orientation?
□ Heterosexual
□ Homosexual
□ Bisexual
□ Questioning
□ Other _____________________________________________ (please specify)
54. Do you have health insurance?
□ Yes
□ No
□ Don‟t know/Not sure
□ Prefer not to answer
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APPENDIX E:
Respondent Debriefing Questionnaire

After completion of each section of the interview, participants will be asked the following
questions to illicit feedback about the survey instrument in terms of clarity, comprehensiveness,
and acceptability. The research assistant will be encouraged to expand on these questions
according to the responses from the participant.
Name of Respondent:

_______________________

Name of Interviewer:

________________________

Start Time:

_________________________

Stop Time:

__________________________
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1. Overall, how did you feel about this survey?
2. Were the instructions clear and easy to follow?

a) If not, can you tell me how we could improve the instructions?
3. Where any sections of the survey unclear or difficult to navigate?

a) Do you have any suggestions as to how we could improve the section?

4. Where any specific questions unclear or need further explanation?

a) Do you have any suggestions as to how we could improve the question?
5. Were the answer choices able to accurately capture your feelings about the topics?
a) If not, what response items need to be added or altered to better capture your
desired response?

6. Approximately how long did it take you to complete the survey?

a) How did you feel about the time?
7. Do you have any other comments, questions, or suggestions you would like to share
about the survey?
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